For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

K.v. Pharmaceutical Company

Calculating rank

USPTO Granted Patents = 25

% Expired Patents = 12.0

Trademarks = 3

Forward Citations = 1,368

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

George N Paradissis (8 out of 18 patents)

Mitchell I Kirschner (7 out of 21 patents)

Robert C Cuca (7 out of 16 patents)

4. R Saul Levinson (6 out of 31 patents)

5. James A Garegnani (5 out of 5 patents)

6. Thomas Charles Riley, Jr (5 out of 6 patents)

7. Thomas C Riley (4 out of 9 patents)

8. Marc S Hermelin (4 out of 13 patents)

9. Roy S Whaley (4 out of 4 patents)

10. Keith S Lienhop (4 out of 5 patents)

11. Victor M Hermelin (3 out of 5 patents)

12. Michael N Grimshaw (2 out of 2 patents)

13. Donald J Barbieri (2 out of 2 patents)

14. Louise M Vizzini (2 out of 2 patents)

15. Steve F Marsh (2 out of 2 patents)

Core Competencies:

Rapidly Disintegrable Tablets

Bioadhesive Drug Delivery

Mineral Supplement

Long Acting Protectant

Tastemasked Formulations

Extended Release

Vaginal Delivery System

Controlled Release Emulsions

Sachet Drug Delivery

Tamper Evident Capsule

Fibre Formulations

Topical Emulsions

25 patents: Sort by Forward Citations

1. 7425341 - Rapidly disintegrable tablets (2008-09-16),

2. 7282217 - Rapidly disintegrable tablets (2007-10-16),

3. 6899890 - Bioadhesive drug delivery system (2005-05-31),

4. 6793935 - Mineral supplement (2004-09-21),

5. 6214379 - Maximizing effectiveness of substances used to improve health and well being (2001-04-10),

6. 5945123 - Maximizing effectiveness of substances used to improve health and well (1999-08-31),

7. 5858391 - Long acting GI and esophageal protectant (1999-01-12),

8. 5730997 - Tastemasked liquid pharmaceutical delivery system (1998-03-24),

9. 5554380 - Bioadhesive pharmaceutical delivery system (1996-09-10),

10. 5554379 - Long acting GI and esophageal protectant (1996-09-10),

11. 5494681 - Tastemasked pharmaceutical materials (1996-02-27),

12. 5445829 - Extended release pharmaceutical formulations (1995-08-29),

13. 5296232 - Pharmaceutical formulation which does not induce tolerance (1994-03-22),

14. 5266329 - Vaginal delivery system (1993-11-30),

15. 5133974 - Extended release pharmaceutical formulations (1992-07-28),

Company Overview

K.V. Pharmaceutical Company, headquartered in St. Louis, Missouri, specializes in the development and manufacturing of pharmaceutical products. The company focuses on providing high-quality medications, particularly in the areas of women's health and specialty pharmaceuticals. K.V. Pharmaceutical is committed to advancing healthcare solutions through innovative research and development, ensuring that patients have access to effective treatments. Its dedication to quality and compliance positions it as a key player in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

25 Patents

#94 in St. Louis, MO

#194 in Missouri

#13,379 in US

#25,748 in the World

St. Louis, MO, United States of America

K.v. Pharmaceutical Company

Forward Citations = 1,368

21 inventors:

George N Paradissis (8 out of 18 patents)

Mitchell I Kirschner (7 out of 21 patents)

Robert C Cuca (7 out of 16 patents)

4. R Saul Levinson (6 out of 31 patents)

5. James A Garegnani (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: K.v. Pharmaceutical Company. Retrieved from https://idiyas.com/company/k-v-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…